Your browser doesn't support javascript.
loading
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis.
Walker, Timothy M; Miotto, Paolo; Köser, Claudio U; Fowler, Philip W; Knaggs, Jeff; Iqbal, Zamin; Hunt, Martin; Chindelevitch, Leonid; Farhat, Maha; Cirillo, Daniela Maria; Comas, Iñaki; Posey, James; Omar, Shaheed V; Peto, Timothy Ea; Suresh, Anita; Uplekar, Swapna; Laurent, Sacha; Colman, Rebecca E; Nathanson, Carl-Michael; Zignol, Matteo; Walker, Ann Sarah; Crook, Derrick W; Ismail, Nazir; Rodwell, Timothy C.
Afiliação
  • Walker TM; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Miotto P; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Köser CU; San Raffaele Scientific Institute, Milano, Italy.
  • Fowler PW; Department of Genetics, University of Cambridge, Cambridge, UK.
  • Knaggs J; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Iqbal Z; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Hunt M; European Bioinformatics Institute, Hinxton, UK.
  • Chindelevitch L; European Bioinformatics Institute, Hinxton, UK.
  • Farhat M; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Cirillo DM; European Bioinformatics Institute, Hinxton, UK.
  • Comas I; Imperial College London, UK.
  • Posey J; Havard Medical School, Boston, USA.
  • Omar SV; San Raffaele Scientific Institute, Milano, Italy.
  • Peto TE; CIBER Epidemiology and Public Health, Madrid, Spain.
  • Suresh A; Centres for Disease Control and Prevention, Atlanta, USA.
  • Uplekar S; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Laurent S; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Colman RE; NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Nathanson CM; The Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Zignol M; The Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Walker AS; The Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Crook DW; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland,*.
  • Ismail N; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Rodwell TC; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lancet Microbe ; 3(4): e265-e273, 2022 04.
Article em En | MEDLINE | ID: mdl-35373160
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Etambutol / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Microbe Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Etambutol / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Microbe Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido